Edition:
United Kingdom

Neuralstem Inc (CUR.OQ)

CUR.OQ on NASDAQ Stock Exchange Capital Market

1.18USD
17 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.18
Open
$1.18
Day's High
$1.20
Day's Low
$1.18
Volume
4,317
Avg. Vol
20,842
52-wk High
$3.09
52-wk Low
$0.89

Chart for

About

Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189... (more)
No analyst recommendations are available for .

Overall

Beta: 1.58
Market Cap(Mil.): $16.36
Shares Outstanding(Mil.): 12.12
Dividend: --
Yield (%): --

Financials

  CUR.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -2.24 -- --
ROI: -291.84 15.07 14.61
ROE: -536.03 16.59 16.33

BRIEF-Neuralstem Announces First Surgery Completed In Cervical Cohort Of Phase 1 Clinical Trial In Patients With Chronic Spinal Cord Injury

* NEURALSTEM ANNOUNCES FIRST SURGERY COMPLETED IN CERVICAL COHORT OF PHASE 1 CLINICAL TRIAL IN PATIENTS WITH CHRONIC SPINAL CORD INJURY Source text for Eikon: Further company coverage:

10 Apr 2018

BRIEF-Neuralstem Says At Dec. 31, 2017, Cash And Investments Was $11.7 Mln Compared To $20.2 Mln At Dec. 31, 2016

* NEURALSTEM REPORTS YEAR END 2017 FISCAL RESULTS AND BUSINESS UPDATE

02 Apr 2018

Earnings vs. Estimates